25-HydroxyvitaMin D3 3-Glucuronide
- $245 - $700
- Product name: 25-HydroxyvitaMin D3 3-Glucuronide
- CAS: 170512-14-8
- MF: C33H52O8
- MW: 576.76
- EINECS:
- MDL Number:
- Synonyms:25-HydroxyvitaMin D3 3-Glucuronide;25-HydroxyvitaMin D3 3-Glucuronide >90%;RYOQRDXVFJRWFJ-AHYWSSLSSA-N;25-Hydroxyvitamin D3 3-Glucuronide >β-D-Glucopyranosiduronic acid, (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylenecyclohexyl
3 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
- Usbiological
Package
- 500ug
- 0.5mg
- ManufacturerMedical Isotopes, Inc.
- Product number65560
- Product description25-HydroxyvitaminD33-Glucuronide>90%
- Packaging0.5mg
- Price$700
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberH995880
- Product description25-HydroxyvitaminD33-Glucuronide>90%
- Packaging0.5mg
- Price$245
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number160144
- Product description25-Hydroxyvitamin D3 3-Glucuronide
- Packaging500ug
- Price$531
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 65560 | 25-HydroxyvitaminD33-Glucuronide>90% | 0.5mg | $700 | 2021-12-16 | Buy |
TRC | H995880 | 25-HydroxyvitaminD33-Glucuronide>90% | 0.5mg | $245 | 2021-12-16 | Buy |
Usbiological | 160144 | 25-Hydroxyvitamin D3 3-Glucuronide | 500ug | $531 | 2021-12-16 | Buy |
Properties
Melting point :>114oC (dec.)
storage temp. :Amber Vial, -86°C Freezer, Under inert atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :White to Pale Brown
Stability :Light Sensitive, Hygroscopic
storage temp. :Amber Vial, -86°C Freezer, Under inert atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :White to Pale Brown
Stability :Light Sensitive, Hygroscopic
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|